NasdaqGS:ANAB
NasdaqGS:ANABBiotechs

AnaptysBio (ANAB): Assessing an 8x Price-to-Sales Valuation After a Strong Share Price Run-Up

AnaptysBio (ANAB) has quietly turned into a strong momentum story, with the stock up about 3% on the day, roughly 9% over the past week, and more than 30% this month. See our latest analysis for AnaptysBio. Zooming out, that sharp 1 day and 30 day share price momentum sits on top of a powerful year to date share price return, while the 1 year total shareholder return shows that optimism has been building for some time. If AnaptysBio's surge has you rethinking your exposure to biotech, it...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Luckin’s Rapid Expansion And Premium Acquisition Talks Might Change The Case For Investing In LKNC.Y

In recent weeks, Luckin Coffee reported double-digit growth in store count, monthly active customers, same-store sales, and revenue, while also confirming it is in early-stage talks to acquire premium brands such as Nestlé’s Blue Bottle Coffee and the operator of % Arabica’s China business. This combination of rapid operational expansion and a potential move upmarket into premium coffee suggests Luckin is testing how far its model can stretch beyond low-priced, app-driven beverages. With...